Interactive Transcript
0:00
Now the A CR Lung Cancer Screening Committee had a working
0:04
group that took all of the white papers that have come out
0:08
of the A CR for incidental findings
0:10
and pulled together those that you might see in a chest ct.
0:13
So lower neck, chest, and upper abdominal findings.
0:17
And so you'll see on this a CR lung cancer screening,
0:21
CT incidental finding quick reference guide,
0:23
those findings are all pulled into one space.
0:26
This was pulled together for two reasons.
0:29
One, we had primary care physicians
0:32
and organizations like folks at the American Academy
0:34
of Family Physicians say,
0:36
I understand radiology can do low dose chest CT
0:40
for lung cancer screening
0:41
and do it with low radiation exposure.
0:43
One of our biggest concerns is all the incidental findings
0:46
that you radiologists detect
0:48
and we need help understanding what needs
0:51
to be managed and what doesn't.
0:53
And the other input to this where nurse navigators
0:55
and coordinators and lung cancer screening programs
0:58
who are getting these reports back
1:00
and not knowing what to do with findings
1:02
or getting questions from patients.
1:04
Remember these are patients who are generally
1:06
otherwise healthy from a thoracic
1:08
and cardiovascular standpoint.
1:10
So you'll see that we have findings by each
1:12
of the body parts, adrenal, kidney, liver, pancreas, so some
1:15
of the upper abdominal findings
1:17
and musculoskeletal findings like bone mineral density
1:20
that could be reported on each CT
1:23
by simply putting a a cursor
1:24
or region of interest on your L one vertebral body if you
1:27
have it, if not T 12, to measure density as a measure
1:30
of osteopenia or osteoporosis,
1:33
which is an important population health type of measurement.
1:37
This is the front and backside
1:39
of the CT incidental findings.
1:40
Quick reference guide and you'll see not only the abdominal
1:44
musculoskeletal systems, you'll see cardiovascular, breast,
1:48
esophagus, lung, pleura, mediastinum and thyroid findings.
1:52
Now wherever you see, okay, it's intended to indicate
1:55
to the primary care physician or nurse navigator
1:58
and coordinator that there's no action needed.
2:01
But where you see something in bold, those are the type
2:04
of findings where a management recommendation is made.
2:06
So for example, if you look under lung atelectasis,
2:10
that's mild or subsegmental, okay?
2:13
No action is needed if you have emphysema
2:16
and wall thickening,
2:17
while it might be an expected finding in somebody who's
2:20
smoked, you should consider PCP evaluation
2:23
and may benefit from a pulmonary consult.
2:26
For fibrotic ILD, we come down a little bit more firmer
2:30
fibrotic ILD is progressive, so pulmonary fibrosis
2:34
and it's can be treated with antifibrotics.
2:37
So referral to pulmonary medicine is critically important if
2:40
a patient is not known to have fibrotic ILD
2:42
before screening and so on.
2:44
So this is intended to be a quick guide again focused on
2:47
primary care providers or nurse navigators,
2:50
but it can also be useful for the to the radiologist
2:52
and pulling it all together in one place to be able
2:55
to make a good recommendation
2:56
to your primary care physicians, uh,
2:58
when they get the results back for their screening tests
3:01
so they know what to do
3:02
and you've been the one that's helped them do that.
3:05
I'll just talk about a couple findings
3:07
and one that I think is particularly important is coronary
3:09
artery calcification as a marker of atherosclerosis.
3:13
We know it correlates with the extent
3:15
of atherosclerotic plaque
3:16
and can be used to predict coronary heart disease risk.
3:19
It's a common finding on chest cts.
3:21
In general, over half of patients with no history
3:24
of coronary disease may have coronary art.
3:26
Total calcification. It's seen in about 40%
3:29
of people over the age of 40
3:31
and about 25% of people undergoing a CT exam
3:34
for pulmonary embolism.
3:35
So these are not screening cts
3:37
and yet we're seeing it in high numbers
3:40
whenever we see coronary arterial calcification.
3:42
It's important that we include it in our reports
3:46
in our structured field of our reports
3:48
for lung cancer screening.
3:50
In fact, for all chest cts we have a standard section
3:53
for cardiovascular findings
3:55
and one specifically for coronary artery calcification
3:58
where we pick whether it's non mild, moderate or severe.
4:02
And that's in all
4:03
of our chest CT reports including screening.
4:06
There are software tools
4:07
that will now help you actually do a true tson coronary
4:10
artery calcium score on any chest ct
4:13
and we're starting to see slow implementation
4:15
of those in practice if you have heavier,
4:18
severe calcification in the moderate
4:20
or severe range, that's
4:22
where cardiovascular risk assessment is really important
4:25
as well as the referring physician PCP evaluating clinically
4:29
for signs and symptoms of cardiovascular disease.
4:33
There is a society of cardiac
4:35
cts TR 2016 guideline which recommends reporting coronary
4:40
arterial calcification on all patients cts irrespective
4:43
of the scan indication
4:45
or their patient risk status for cardiovascular disease.
4:48
And I was, uh, grateful
4:49
to be a participant in the production of that work.
4:52
So if you see coronary arter calcification reported
4:55
non mild, moderate severe is a grading system which
4:58
correlates well with the tson scoring system as shown
5:02
by a nice study by Carolyn Chiles et al
5:04
who looked at the NLST data.
5:07
This is the translation of the visual score
5:10
to the TSON score.
5:11
The traditional way of doing a dedicated coronary calcium
5:15
calculation exam.
5:17
The non mild moderate severe visual score correlates very
5:21
well with the tson score categories
5:24
and these categories of the different amounts
5:26
of increasing calcium correlate with a patient's risk
5:30
of subsequent downstream cardiovascular events from very low
5:34
risk to high risk.
5:36
So a patient with no coronary calcium has a risk event rate
5:39
of two per thousand annually, whereas a patient
5:42
with moderate coronary calcium
5:44
has a greater than two per hundred chance
5:47
of having a cardiovascular event annually.
5:50
Patients with severe coronary calcification,
5:52
whether visually or by calcium score over 400 have a
5:56
between two and five chance per hundred
5:59
or a 15% chance
6:00
of having obstructive coronary disease at the time the exam
6:04
was read and consideration should be given to stress echo
6:07
or stress nuclear exam.
6:09
In this case, when we see severe coronary trial
6:12
calcification, the patient hasn't seen a cardiologist.
6:15
This is something that our primary care physicians
6:18
would usually refer for.
6:20
And here's an example using the tson scoring system,
6:24
or you can use the visual non mild, moderate severe system.
6:27
So here's the traditional uh, calculation
6:30
of coronary calcium, which can actually be done on non
6:34
coronary calcium cts.
6:35
You can do this on a lung cancer screening CT if you want
6:38
to, and there are software tools that you can use to apply
6:41
to all chest cts to do this to calculate a true AON score.
6:46
More practices are currently using the non mild moderate
6:48
severe categorization.
6:50
In this case it would be severe multi-vessel
6:53
coronary trail calcification.
6:56
Another cardiovascular, uh, finding that's important
6:59
to report is dilatation or aneurysms of the aorta.
7:03
They tend to be silent compared
7:05
to abdominal aortic aneurysms and less well understood
7:09
and less frequently detected
7:10
before patients come in with signs
7:13
of thoracic aortic aneurysm.
7:15
Acute rupture, an aneurysm is defined as 150%
7:20
of normal diameter.
7:21
So in the aorta we consider five centimeters an aneurysm in
7:25
the ascending and four centimeters in the descending aorta.
7:29
Below that, between normal
7:31
and that size we consider dilated.
7:33
So we'll also often report them as fusiform dilatation
7:36
of the ascent aorta when it hits 40 millimeters or larger.
7:42
The freemium heart study that used ECGG non-contrast a T
7:46
and several thousand individuals has reported
7:48
what the norms are with a standard deviation around it
7:52
for men and women.
7:54
But it's important that we do things like adjust
7:56
for patient size.
7:58
Unfortunately, there are no good nomograms for us to use
8:01
as radiologists in practice to say a 38 millimeter aorta
8:05
and a tiny person is probably abnormal,
8:07
whereas a 42 millimeter aorta in the A setting is probably
8:10
normal in a larger individual, we don't have that degree
8:13
of information available
8:15
to us at the time of interpretation.
8:17
Whenever the thoracic aorta,
8:19
especially the ascending is greater than five
8:21
and a half centimeters, it should be a referral
8:23
to cardiac surgery because of the high risk of rupture
8:27
and even smaller at five centimeters if patients have
8:30
underlying diseases like Marfans
8:31
or Alos Danlos
8:33
where surgical replacement is often done earlier,
8:36
if you're particularly interested in the thoracic aorta,
8:39
there is an updated American College of cardiology,
8:42
a HA guideline for the diagnosis
8:44
and management of aortic disease.
8:47
It has, uh, had a widespread adoption uptake since its
8:51
publication and it looks at this issue of aortic
8:54
Size and the relative risk
8:56
of having an aortic dissection, for example.
8:59
So once you hit four centimeters
9:01
or greater in the ascent aorta, your risk of rupture starts
9:05
to go up or aortic dissection
9:06
and your risk gets particularly high if your
9:08
as centimeter is four
9:09
and a half centimeters, which is why we use this 40
9:13
millimeter ascending aortic diameter as important to report.
9:17
So that's a look at some important incidental findings on
9:21
lung cancer screening, the philosophy
9:23
behind why it's important
9:25
and some of the specific findings
9:27
that we can make a difference for our patients.